<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02601742</url>
  </required_header>
  <id_info>
    <org_study_id>HGNAE-09</org_study_id>
    <nct_id>NCT02601742</nct_id>
  </id_info>
  <brief_title>Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute</brief_title>
  <official_title>Effectiveness of Oral Rehydration Therapy Supplemented With Zinc in the Management of Diarrhea Acute in Mexican Children: Randomized Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Naval de Alta Especialidad - Escuela Medico Naval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Naval de Alta Especialidad - Escuela Medico Naval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute diarrhea is the third cause of infant mortality in the world causing 15% of all deaths
      in children under 5 years and is responsible for nearly 1.4 million deaths in developing
      countries. It is considered a self-limiting disease and to this problem the recommendation of
      the World Health Organization (WHO) is the administration of zinc with low osmolarity oral
      dehydration salts for a period of 10-14 days which reduces the severity of the episode.

      In Mexico COFEPRIS believes the zinc salt as a food supplement and not a drug and the above
      problem is presented in terms of prescribing and access of this salt to the general
      population. In Mexico the investigators have the provision and accessibility of low
      osmolarity oral dehydration salts supplemented with adequate doses of zinc, which is
      inexpensive for the general population and offering a solution in terms of supply and
      management.

      The purpose of the study involves the evaluation Pedialyte diarrhea in the treatment of acute
      diarrhea in children under 5 years. The investigator sconsider the use of Pedialyte diarrhea
      eases their access to the population in general and it is low cost compared with the zinc
      salt that is sold only in specialized pharmacies under strict medical prescription Objective:
      Compare the duration of symptoms of acute diarrhea in the treatment with low osmolarity oral
      rehydration salts (Pedialyte) vs treatment of low osmolarity oral rehydration supplemented
      with zinc (Pedialyte diarrhea) Study Desing: Double blind, randomized, controlled.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It will be conducted a randomized controlled double-blind in the Emergency service of the
      Naval General Hospital of High Specialty in the Mexico City. The period of patient inclusion
      in the study is October 2015 to November 2016.

      The patients selections is the children between 6 months and 5 years who come to the
      emergency room with symptoms of acute diarrhea with up to 48 hours of starting the disease,
      it will proceed to questioning and to assess vital signs and thorough physical examination
      for determine the degree of dehydration, nutritional status and rule out diagnosis of
      abdominal pathology emergency.

      Selection criteria Inclusion

        -  Patients 6 months to 5 years old with acute diarrhea

        -  Patients in their first 48 hours of onset diarrhea

        -  Dehydration mild to moderate according to WHO clinical scale

        -  Both sexes

        -  Outpatients

      Exclusion

        -  Patients with vomit (10 or more)

        -  Hemodynamic Instability

        -  Dehydration severe

        -  Patients with heart disease

        -  Patients with a history of prematurity.

        -  Patients with chronic diarrhea

        -  Patients whose parents refuse to provide written informed consent

        -  Patients who do not comply with treatment correctly

        -  Patients with suspected surgical pathology

      Elimination

        -  Patients with severe dehydration

        -  Patients in whom the parents decline for informed consent
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of bowel movements per day</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Diarrhea</condition>
  <condition>Children</condition>
  <arm_group>
    <arm_group_label>Zinc group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pedialyte oral electrolyte solution, 330 ml per day for 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Zinc group</intervention_name>
    <description>Pedialyte diarrhea oral electrolyte solution, 330 ml per day for 7 days</description>
    <arm_group_label>Zinc group</arm_group_label>
    <other_name>Pedialyte diarrhea 45</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo group</intervention_name>
    <description>Pedialyte oral electrolyte solution, 330 ml per day for 7 days</description>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Pedialyte SR 45</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 6 months to 5 years old with acute diarrhea

          -  Patients in their first 48 hours of onset diarrhea

          -  Dehydration mild to moderate according to WHO clinical scale

          -  Both sexes

          -  Outpatients

        Exclusion Criteria:

          -  Patients with vomit (10 or more)

          -  Hemodynamic Instability

          -  Severe dehydration

          -  Patients with heart disease

          -  Patients with a history of prematurity.

          -  Patients with chronic diarrhea

          -  Patients whose parents refuse to provide written informed consent

          -  Patients who do not comply with treatment correctly

          -  Patients with suspected surgical pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María del Carmen Yebra Cano, Medicina</last_name>
    <role>Principal Investigator</role>
    <affiliation>Secretaria de Marina-Armada de México (Mexican Navy)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>María del Carmen Yebra Cano, Medicina</last_name>
    <phone>5585315297</phone>
    <email>melitacar@hotmail.com</email>
  </overall_contact>
  <link>
    <url>http://www.insp.mx</url>
    <description>Encuesta Nacional de Salud y Nutrición 2012</description>
  </link>
  <reference>
    <citation>Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE; Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012 Jun 9;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11. Erratum in: Lancet. 2012 Oct 13;380(9850):1308.</citation>
    <PMID>22579125</PMID>
  </reference>
  <reference>
    <citation>Gupta GR. Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children. Lancet. 2012 Jun 9;379(9832):2123-4. doi: 10.1016/S0140-6736(12)60907-6.</citation>
    <PMID>22682449</PMID>
  </reference>
  <reference>
    <citation>Aurelio Mejia y cosl., Analisis de costo beneficio de la suplementación con Zinc en el tratamiento de la diarrea aguda en niños menores de 5 años en Colombia, publicado en ESPGHAN 2015</citation>
  </reference>
  <reference>
    <citation>Scrimgeour, A.; Condlin, M.; Otieno, L.; Bovill, M. Zinc intervention strategies: Costs and health benefits. In Nutrients, Dietary Supplements, and Nutriceuticals; Gerald, J.K., Watson, R.R., Preedy, V.R., Eds.; Humana Press: 201</citation>
  </reference>
  <reference>
    <citation>WHO/UNICEF. Joint Statement on the Clinical Management of Acute Diarrhoea; UNICEF: 2004</citation>
  </reference>
  <reference>
    <citation>Benguigui Y, Bernal C, Figueroa D, eds. Manual de Tratamiento de la Diarrea en Nin˜os. Washington, DC: Panamerican Health Organization/ Organización Panamericana de la Salud; 2008</citation>
  </reference>
  <reference>
    <citation>Malek MA, Curns AT, Holman RC, Fischer TK, Bresee JS, Glass RI, Steiner CA, Parashar UD. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006 Jun;117(6):1887-92.</citation>
    <PMID>16740827</PMID>
  </reference>
  <reference>
    <citation>Majowicz SE, McNab WB, Sockett P, Henson TS, Doré K, Edge VL, Buffett MC, Fazil A, Read S, McEwen S, Stacey D, Wilson JB. Burden and cost of gastroenteritis in a Canadian community. J Food Prot. 2006 Mar;69(3):651-9.</citation>
    <PMID>16541699</PMID>
  </reference>
  <reference>
    <citation>Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev. 2012 Jun 13;(6):CD005436. doi: 10.1002/14651858.CD005436.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;(1):CD005436.</citation>
    <PMID>22696352</PMID>
  </reference>
  <reference>
    <citation>Liberato SC, Singh G, Mulholland K. Zinc supplementation in young children: A review of the literature focusing on diarrhoea prevention and treatment. Clin Nutr. 2015 Apr;34(2):181-8. doi: 10.1016/j.clnu.2014.08.002. Epub 2014 Aug 13. Review.</citation>
    <PMID>25176404</PMID>
  </reference>
  <reference>
    <citation>Dr Rul L. Riveron Corteguera, Fisiopatología de la diarrea aguda, Hospital pediátrico docente de la Habana 2009</citation>
  </reference>
  <reference>
    <citation>King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr. 2000 May;130(5S Suppl):1360S-6S. doi: 10.1093/jn/130.5.1360S. Review.</citation>
    <PMID>10801944</PMID>
  </reference>
  <reference>
    <citation>Baqui AH, Black RE, El Arifeen S, Yunus M, Chakraborty J, Ahmed S, Vaughan JP. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ. 2002 Nov 9;325(7372):1059.</citation>
    <PMID>12424162</PMID>
  </reference>
  <reference>
    <citation>Fischer Walker CL, Fontaine O, Young MW, Black RE. Zinc and low osmolarity oral rehydration salts for diarrhoea: a renewed call to action. Bull World Health Organ. 2009 Oct;87(10):780-6.</citation>
    <PMID>19876545</PMID>
  </reference>
  <reference>
    <citation>Maggini S, Wenzlaff S, Hornig D. Essential role of vitamin C and zinc in child immunity and health. J Int Med Res. 2010 Mar-Apr;38(2):386-414. Review.</citation>
    <PMID>20515554</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2015</study_first_submitted>
  <study_first_submitted_qc>November 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2015</study_first_posted>
  <last_update_submitted>November 9, 2015</last_update_submitted>
  <last_update_submitted_qc>November 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>zinc</keyword>
  <keyword>Duration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Zinc</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

